Role of Na
BK channel
NCX
brain tumor
cell migration
glioblastoma
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Aug 2023
11 Aug 2023
Historique:
received:
12
07
2023
revised:
07
08
2023
accepted:
08
08
2023
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
26
8
2023
Statut:
epublish
Résumé
Glioblastoma (GBM) is the most malignant form of primary brain tumor. It is characterized by the presence of highly invasive cancer cells infiltrating the brain by hijacking neuronal mechanisms and interacting with non-neuronal cell types, such as astrocytes and endothelial cells. To enter the interstitial space of the brain parenchyma, GBM cells significantly shrink their volume and extend the invadopodia and lamellipodia by modulating their membrane conductance repertoire. However, the changes in the compartment-specific ionic dynamics involved in this process are still not fully understood. Here, using noninvasive perforated patch-clamp and live imaging approaches on various GBM cell lines during a wound-healing assay, we demonstrate that the sodium-calcium exchanger (NCX) is highly expressed in the lamellipodia compartment, is functionally active during GBM cell migration, and correlates with the overexpression of large conductance K+ channel (BK) potassium channels. Furthermore, a NCX blockade impairs lamellipodia formation and maintenance, as well as GBM cell migration. In conclusion, the functional expression of the NCX in the lamellipodia of GBM cells at the migrating front is a conditio sine qua non for the invasion strategy of these malignant cells and thus represents a potential target for brain tumor treatment.
Identifiants
pubmed: 37628853
pii: ijms241612673
doi: 10.3390/ijms241612673
pmc: PMC10454658
pii:
doi:
Substances chimiques
Sodium-Calcium Exchanger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Ministry of Health
ID : Project IMMUNO- 709 HUB,T4-CN-02
Références
Cell Calcium. 2013 Apr;53(4):241-55
pubmed: 23357407
Nat Commun. 2022 Oct 17;13(1):6128
pubmed: 36253369
Expert Opin Investig Drugs. 2004 Jun;13(6):653-64
pubmed: 15174951
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Exp Biol Med (Maywood). 2008 Jul;233(7):779-91
pubmed: 18445774
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7):
pubmed: 33579821
J Neurosurg. 2011 Jul;115(1):3-8
pubmed: 21417701
Biochem Pharmacol. 2019 May;163:357-361
pubmed: 30826328
Front Neurosci. 2020 Nov 30;14:595664
pubmed: 33328867
Oncogene. 2022 Aug;41(35):4169-4182
pubmed: 35882979
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1985-96
pubmed: 25053711
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Eur J Neurosci. 1994 Apr 1;6(4):640-5
pubmed: 7912985
Cell Mol Neurobiol. 2020 Jul;40(5):813-828
pubmed: 31845161
J Gen Physiol. 2014 May;143(5):577-604
pubmed: 24778430
Adv Exp Med Biol. 2013;961:49-54
pubmed: 23224869
Br J Pharmacol. 2019 Aug;176(15):2691-2707
pubmed: 31034096
J Neurol. 2018 Jun;265(6):1432-1442
pubmed: 29687214
Int J Mol Sci. 2019 May 30;20(11):
pubmed: 31151189
Nature. 2004 Feb 5;427(6974):544-8
pubmed: 14765196
ISRN Neurol. 2011;2011:590249
pubmed: 22389824
J Biol Chem. 2013 Nov 1;288(44):31984-92
pubmed: 24045952
Cell Mol Neurobiol. 2010 Apr;30(3):453-60
pubmed: 19830548
J Cell Physiol. 2018 Jan;233(1):363-370
pubmed: 28262948
Cancers (Basel). 2019 Mar 05;11(3):
pubmed: 30841564
J Gen Physiol. 1988 Aug;92(2):145-59
pubmed: 2459299
Front Cell Neurosci. 2015 Apr 20;9:152
pubmed: 25941475
Biomolecules. 2020 Aug 31;10(9):
pubmed: 32878087
Biol Chem. 2023 Jan 04;404(4):325-337
pubmed: 36594183
J Physiol. 2000 Dec 15;529 Pt 3:611-23
pubmed: 11195933
Front Physiol. 2022 Jun 22;13:827334
pubmed: 35812308
Genes Dev. 2001 Jun 1;15(11):1311-33
pubmed: 11390353
Neurol Res Int. 2012;2012:878425
pubmed: 22530127
Biophys J. 2007 Oct 1;93(7):2504-18
pubmed: 17557789
J Cell Physiol. 2023 Jul 11;:
pubmed: 37431808
Cell Calcium. 2020 Sep;90:102241
pubmed: 32562975
Cell Calcium. 1999 Apr;25(4):321-31
pubmed: 10456229
Adv Exp Med Biol. 2013;961:289-94
pubmed: 23224888
J Physiol. 2014 Nov 15;592(22):4969-93
pubmed: 25239455
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130095
pubmed: 24493743
Pharmacol Rev. 2004 Dec;56(4):633-54
pubmed: 15602012
Eur J Neurosci. 1996 Jun;8(6):1182-9
pubmed: 8752588
Front Pharmacol. 2015 Jul 29;6:152
pubmed: 26283962
J Neurosci. 2001 Oct 1;21(19):7674-83
pubmed: 11567057
Oncotarget. 2016 Jun 21;7(25):38638-38657
pubmed: 27229535
Br J Pharmacol. 2014 Jul;171(14):3432-47
pubmed: 24641279